EX-23.1 9 a2312024consentofaccountin.htm EX-23.1
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements of Cumberland Pharmaceuticals Inc. (the “Company”) on Form S-3 (No. 333-251308) and Forms S-8 (No. 333-164376 and 333-271978) of our report dated March 7, 2025, with respect to the consolidated financial statements of the Company, included in this Annual Report on Form 10-K for the year ended December 31, 2024.
/s/ Carr, Riggs & Ingram, LLC
Nashville, Tennessee
March 7, 2025